GEVA

Synageva BioPharma Corp. News Headlines

$115.95
*  
0.63
0.55%
Get GEVA Alerts
*Delayed - data as of Jan. 29, 2015 11:07 ET  -  Find a broker to begin trading GEVA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GEVA Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Synageva Starts Dosing in Phase I/II Study for Sanfilippo B - Analyst Blog
1/28/2015 6:25:00 PM - Zacks.com


Synageva Starts Dosing in Phase I/II Study for Sanfilippo B - Analyst Blog
1/28/2015 6:25:00 AM - Investopedia


PFE Cuts Vaccine Price, CVM On Track, BABY Takes New Step, IPXL On A High
1/27/2015 4:42:00 AM - RTT News


Why You Shouldn't Bet Against Synageva BioPharma (GEVA) Stock - Tale of the Tape
1/12/2015 8:58:00 AM - Zacks.com


3 Biotech Stocks Focused on Curing Ultra-Rare Diseases
1/11/2015 2:41:02 PM - Motley Fool


InsiderInsights.com Daily Round Up 1/9/15: OAS, OPK, RM, VVUS
1/11/2015 1:09:00 AM - Seeking Alpha


Use Options For a Chance To Buy GEVA at a 25% Discount
1/8/2015 11:47:00 AM - BNK Invest


Synageva Prices Public Offering At $94.19 Per Share
1/6/2015 7:28:00 PM - RTT News


Synageva (GEVA) Stock: Moving Average Crossover Alert - Tale of the Tape
12/29/2014 9:03:01 AM - Zacks.com


Can the Rally in Synageva Biopharma (GEVA) Shares Continue? - Tale of the Tape
12/10/2014 9:38:57 AM - Zacks.com


Synageva Completes BLA Submission for Sebelipase Alfa - Analyst Blog
12/4/2014 3:10:00 PM - Zacks.com


Synageva BioPharma (GEVA): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
11/25/2014 8:55:00 AM - Zacks.com


Synageva Up on New Phase III Data on Sebelipase Alfa - Analyst Blog
11/14/2014 3:40:00 PM - Zacks.com


Synageva BioPharma To Present At  Nomura Bio Conference; Webcast At 8:00 AM ET
11/6/2014 7:00:00 AM - RTT News


Synageva Slips on Wider-than-Expected Q2 Loss - Analyst Blog
8/1/2014 3:30:00 PM - Zacks.com


Thursday's ETF Movers: BSCF, XBI
7/31/2014 12:38:01 PM - BNK Invest


Sector Update: Health Care
7/18/2014 12:33:31 PM - MT Newswires


Sector Update: Health Care Stocks Following Broader Markets Highers; GlycoMimetics Jumps More Than 10% After Naming Cancer-Specialist to Board
7/18/2014 12:32:37 PM - MT Newswires


Synageva's Sebelipase Alfa Meets Primary Endpoint in ARISE - Analyst Blog
7/1/2014 3:00:00 PM - Zacks.com


Synageva's Q1 Loss Narrower than Expected - Analyst Blog
5/1/2014 4:10:01 PM - Zacks.com


Synageva Heading For Big Disappointment
4/22/2014 11:05:00 AM - Seeking Alpha


Synageva Heading For Big Disappointment
4/22/2014 10:00:00 AM - Seeking Alpha


Synageva Heading For Big Disappointment
4/22/2014 9:00:00 AM - SeekingAlpha


Synageva 4Q Loss Narrower-than-Expected Loss - Analyst Blog
3/4/2014 11:00:01 AM - Zacks.com


After-Hours Earnings Report for March 3, 2014 : SCTY, VIPS, GWRE, GEVA, URS, MR, ASNA, MDR, NUVA, DXPE, MCP, AUQ
3/3/2014 2:00:01 PM - NASDAQ.com News